Evaluation of carbapenem-resistant Enterobacteriaceae (CRE) guideline implementation in the Veterans Affairs Medical Centers using the consolidated framework for implementation research
Tóm tắt
Infections caused by carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing (CP) CRE are difficult to treat, resulting in high mortality in healthcare settings every year. The Veterans Health Administration (VHA) disseminated guidelines in 2015 and an updated directive in 2017 for control of CRE focused on laboratory testing, prevention, and management. The Consolidated Framework for Implementation Research (CFIR) framework was used to analyze qualitative interview data to identify contextual factors and best practices influencing implementation of the 2015 guidelines/2017 directive in VA Medical Centers (VAMCs). The overall goals were to determine CFIR constructs to target to improve CRE guideline/directive implementation and understand how CFIR, as a multi-level conceptual model, can be used to inform guideline implementation. Semi-structured interviews were conducted at 29 VAMCs with staff involved in implementing CRE guidelines at their facility. Survey and VHA administrative data were used to identify geographically representative large and small VAMCs with varying levels of CRE incidence. Interviews addressed perceptions of guideline dissemination, laboratory testing, staff attitudes and training, patient education, and technology support. Participant responses were coded using a consensus-based mixed deductive-inductive approach guided by CFIR. A quantitative analysis comparing qualitative CFIR constructs and emergent codes to sites actively screening for CRE (vs. non-screening) and any (vs. no) CRE-positive cultures was conducted using Fisher’s exact test. Forty-three semi-structured interviews were conducted between October 2017 and August 2018 with laboratory staff (47%), Multi-Drug-Resistant Organism Program Coordinators (MPCs, 35%), infection preventionists (12%), and physicians (6%). Participants requested more standardized tools to promote effective communication (e.g., electronic screening). Participants also indicated that CRE-specific educational materials were needed for staff, patient, and family members. Quantitative analysis identified CRE screening or presence of CRE as being significantly associated with the following qualitative CFIR constructs: leadership engagement, relative priority, available resources, team communication, and access to knowledge and information. Effective CRE identification, prevention, and treatment require ongoing collaboration between clinical, microbiology, infection prevention, antimicrobial stewardship, and infectious diseases specialists. Our results emphasize the importance of leadership’s role in promoting positive facility culture, including access to resources, improving communication, and facilitating successful implementation of the CRE guidelines.
Tài liệu tham khảo
Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. Atlanta: U.S. Department of Health and Human Services, CDC; 2019.
Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29(12):1099–106. https://doi.org/10.1086/592412.
Centers for Disease Control and Prevention. CRE technical information. https://www.cdc.gov/hai/organisms/cre/technical-info.html Last accessed 30 June 2020.
VHA National Infectious Disease Service, MDRO Prevention Office. 2015 guideline for control of carbapenem-resistant Enterobacteriaceae (CRE). 2015.
VHA National Infectious Disease Service, MDRO Prevention Office. 2017 guideline for control of carbapenemase producing-carbapenem resistant enterobacteriaceae (CPCRE). 2017.
VHA 2019 Toolkit for Control of Carbapenemase-Producing, Carbapenem-Resistant Enterobacteriaceae (CP-CRE); VHA MDRO Prevention Office, Lexington VA Medical Center, Lexington, KY, 11/22/19. http://vaww.mrsa.va.gov/Carbapenem_resistant_Enterobacteriaceae_CRE.as.
MRSA Initiative U.S. Department of Veterans Affairs VHA. Methicillin-resistant Staphylococcus aureus (MRSA) initiative, VHA Directive 2007–002. 2007. [http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2163]. Last accessed 30 June 2020.
Fitzpatrick MA, Suda KJ, Ramanathan S, Guihan M, Brown C, Safdar N, et al. Laboratory practices for identification and reporting of carbapenem-resistant Enterobacteriaceae in Department of Veterans Affairs facilities. Infect Control Hosp Epidemiol. 2019;40(4):463–6. https://doi.org/10.1017/ice.2019.24.
Ramanathan S, Suda KJ, Fitzpatrick MA, Guihan M, Goedken CC, Safdar N, et al. QUERI CARRIAGE Program. A survey of infection control strategies for carbapenem-resistant Enterobacteriaceae in Department of Veterans Affairs Facilities. Infect Control Hosp Epidemiol. 2020; (in press).
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;5:50.
Creswell J, Plano CV. Designing and conducting mixed methods research. 2nd ed. Thousand Oaks: Sage Publications; 2011.
Johnson RB, Onwuegbuzie AJ. Mixed methods research: a research paradigm whose time has come. Educ Res. 2004;33(7):14–26. https://doi.org/10.3102/0013189X033007014.
Zuchowski JL, Chrystal JG, Hamilton AB, Patton EW, Zephyrin LC, Yano EM, et al. Coordinating care across health care systems for veterans with gynecologic malignancies: a qualitative analysis. Med Care. 2017;55(Suppl 1):S53–60. https://doi.org/10.1097/MLR.0000000000000737.
VHA Office of Productivity Efficiency & Staffing. Facility complexity model. Last accessed 30 June 2020.
O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245–51.
Ryan GW, Bernard RH. Techniques to identify themes. Field Methods. 2003;15(1):85–109. https://doi.org/10.1177/1525822X02239569.
Damschroder, et al. Evaluation of a large-scale weight management program using the consolidated framework for implementation research. Implement Sci. 2013;8:51.
AHRQ’s healthcare-associated infections program. 2019. Agency for Healthcare Research and Quality, Rockville. https://www.ahrq.gov/hai/index.html Last accessed 30 June 2020.
Chen WK, Yang Y, Tan BH. Increased mortality among carbapenemase-producing carbapenem-tesistant carriers who developed isolates of another genotype. Open Forum Infect Dis. 2019;6(2):ofz006.
Centers for Disease Control and Prevention (CDC). Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mort Wkly Rep. 2013;62(9):165–70.
Martin A, Fahrbach K, Zhao Q, Lodise T. Association between carbapenem resistance and mortality among adult, hospitalized patients with serious infections due to Enterobacteriaceae: results of a systematic literature teview and meta-analysis. Open Forum Infect Dis. 2018;5(7):ofy150.
Lee BY, Bartsch SM, Wong KF, Yilmaz SL, Avery TR, Singh A, et al. Simulation show hospitals that cooperate on infection control obtain better results than hospitals acting alone. Health Affairs. 2012;31(10):2295–303. https://doi.org/10.1377/hlthaff.2011.0992.
Huang SS, Avery TR, Song Y, et al. Quantifying interhospital patient sharing as a mechanism for infectious disease spread. Infect Control Hosp Epidemiol. 2011;31(11):1160–9.
Foote MMK, Styles TS, Quinn CL. Assessment of hospital emergency department response to potentially infectious diseases using unannounced mystery patient drills. New York City, 2016. MMWR Morb Mort Wkly Rep. 2017;66(36):945–9.
Ali M, Williams MD. Notice mystery patient drills to assess emergency preparedness for infectious diseases at community health centers in New York City, 2015-2016. J Community Health. 2019;44(2):387–94.
Escuyer KL, Fuschino M, St George K. New York State emergency preparedness and response to influenza pandemics 1918-2018. Trop Med Infect Dis. 201;4:132. https://doi.org/10.3390/tropicalmed4040132.
Carrico RM, Garrett H, Balcom D, Glowicz JB. Infection prevention and control core practices: a roadmap for nursing practice. Nursing. 2018;48(8):28–9.
Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory committee. Infect Control Hosp Epidemiol. 1998;19(6):407–63.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory committee. Infect Control Hosp Epidemiol. 1999;20(4):250–78.
Boyce JM, Pittet D. Healthcare Infection Control Practices Advisory Committee. Society for Healthcare Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol. 2002;23(Suppl12):S3–S40.
Sehulster L, Chin RY. Healthcare Infection Control Practices Advisory Committee. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2003;52(RR-10):1–42.
Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–93.
Behar-Horenstein LS, Guin P, Gamble K, Hurlock G, Leclear E, Philipose M, et al. Improving patient care through patient–family education programs. Hospital Topics. 2005;83(1):21–7. https://doi.org/10.3200/HTPS.83.1.21-27.
Kirchner E, Ritchie M, Pitcock A, Parker LE, Curran GM, Fortney JC. Outcomes of a partnered facilitation strategy to implement primary care-mental health. J Gen Intern Med. 2014;29(suppl 4):S904–12. 29.
Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, et al. Hospital organisation, management, and structure for prevention of health care-associated infection: a systematic review and expert consensus. Lancet Infect Dis. 2015;15(2):212–24.
Ellis I, Howard P, Larson A, Robertson J. From workshop to work practice: an exploration of context and facilitation in the development of evidence-based practice. Worldviews Evid Based Nurs. 2005;2(2):84–93. https://doi.org/10.1111/j.1741-6787.2005.04088.x.
Balbale S, Hill JN, Guihan M, Hogan T, Cameron KA, Goldstein B, et al. Evaluating implementation of methicillin-resistant Staphylococcus aureus (MRSA) prevention guidelines in spinal cord injury centers using PARIHS framework: a mixed methods study. Implement Sci. 2015;10:130.
Dodek P, Cahill NE, Heyland DK. Implementation of clinical practice guidelines. J Parenter Enteral Nutr. 2010;34(6):669–74. https://doi.org/10.1177/0148607110361905.
Krein SL, Damschroder LJ, Kowalski CP, Forman J, Hofer TP, Saint S. The influence of organizational context on quality improvement and patient safety efforts in infection prevention: a multi-center qualitative study. Soc Sci Med. 2010;7(9):1692–701.
Gifford W, Davies B, Edwards N, Griffin P, Lybanon V. Managerial leadership for nurses’ use of research evidence: an integrative review of the literature. Worldviews Evid Based Nurs. 2007;4(3):126–45. https://doi.org/10.1111/j.1741-6787.2007.00095.x.
Rycroft-Malone J, Seers K, Titchen A, Harvey G, Kitson A, McCormack B. What counts as evidence in evidence based practice? J Adv Nurs. 2004;47(1):81–90. https://doi.org/10.1111/j.1365-2648.2004.03068.x.
Pfeiffer CD, Cunningham MG, Poissant T, Furano JP, Townes JM, Leitz A, et al. Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region. Infect Control Hosp Epidemiol. 2014;35(4):356–61. https://doi.org/10.1086/675605.
Shimasaki T, Segreti J, Tomich A, Kim J, Hayden MK, Ling MY. Active screening and interfacility communication of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital. Infect Control Hosp Epidemiol. 2018;39(9):1058–62.
Trepanier P, Mallard K, Muenier D, Pike R, Brown D, Ashby JP, et al. Carbapenem-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures. J Antimicrob Chemother. 2017;72(2):596–603. https://doi.org/10.1093/jac/dkw414.